查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1467891

消化性溃疡药物市场依产品类型（质子帮浦抑制剂、钾竞争性酸阻断剂、抗酸剂、H2拮抗剂、抗生素、溃疡保护剂）、溃疡类型、配销通路和地区2024-2032年

Peptic Ulcer Drugs Market by Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker, Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球消化性溃疡药物市场规模达48亿美元。消化性溃疡的盛行率不断增加，尤其是在老年族群中，以及消费者倾向于使用各种药物而不是侵入性手术，这是推动市场发展的一些关键因素。

消化性溃疡或十二指肠溃疡是一种开放性溃疡，逐渐发展并引发胃、小肠和下食道内壁的缺陷。它们通常是由于发炎、放射治疗、频繁口服和注射阿斯匹灵以及抗发炎药物引起的。如果消化性溃疡未及时治疗，可能会引起中上身剧烈疼痛、体重减轻、内出血和严重失血，需要住院治疗。目前，他们可以用多种药物类型进行治疗，包括质子帮浦抑制剂（PPI）、H2拮抗剂、抗生素、钾竞争性酸阻断剂（P-CAB）、抗酸剂和溃疡保护剂。这些药物可以减轻身体疼痛，提供更多的癒合时间，最大限度地减少胃酸分泌，抵抗细菌感染，并保护胃免受消化液的侵害。因此，消化性溃疡药物被医疗保健从业人员广泛用于治疗胃炎、胃食道逆流（GERD）和十二指肠溃疡。

消化性溃疡药物市场趋势：

消化性溃疡的盛行率不断增加，特别是在老年族群中，是推动市场成长的关键因素之一。此外，不健康的生活习惯和胃癌发病率的上升，导致越来越多的人患有消化性溃疡。再加上消费者对各种消化性溃疡治疗药物而非侵入性手术的倾向不断变化，这反过来又促进了市场的成长。与此一致的是，与外科手术相比，几种类固醇抗发炎药物具有微创性、更实惠，并且可以在确保减少失血的同时实现更快的恢復。此外，消化性溃疡药物的持续批准以及政府对製药公司的药物配方投资也支持了市场的成长。这进一步受到持续进行新药形成临床试验以克服併发症和市面上现有药物无效的影响。此外，消费者越来越意识到经济高效的消化性溃疡药物的好处及其在多个分销管道上的便利性，这有利于市场的成长。用于执行诊断和法医操作的基于人工智慧（AI）的病理测试技术的出现也推动了市场的成长。其他因素，例如为提高产品功效而进行的广泛研发（R＆D）活动以及增加用于开发治疗消化性溃疡的非处方（OTC）药物的投资，正在对市场成长产生积极影响。

本报告回答的关键问题：

  • 迄今为止，全球消化性溃疡药物市场表现如何，未来几年将如何表现？
  • 全球消化性溃疡药物市场的驱动因素、限制因素和机会是什么？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的消化性溃疡药物市场？
  • 依产品类型分類的市场是怎么样的？
  • 根据溃疡类型市场的细分是什么？
  • 基于配销通路的市场区隔是什么？
  • 全球消化性溃疡药物市场竞争格局如何？
  • 谁是全球消化性溃疡药物市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球消化性溃疡药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品类型

  • 质子帮浦抑制剂
    • 市场走向
    • 市场预测
  • 钾竞争性酸阻断剂 (P-CAB)
    • 市场走向
    • 市场预测
  • 抗酸剂
    • 市场走向
    • 市场预测
  • H2-拮抗剂
    • 市场走向
    • 市场预测
  • 抗生素
    • 市场走向
    • 市场预测
  • 溃疡防护
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按溃疡类型

  • 胃溃疡
    • 市场走向
    • 市场预测
  • 十二指肠溃疡
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：按配销通路

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 网路药局
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：驱动因素、限制与机会

  • 概述
  • 司机
  • 限制
  • 机会

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AstraZeneca plc
    • Boehringer Ingelheim International GmbH
    • Novitium Pharma LLC
    • Pfizer Inc.
    • PharmaKing Co. Ltd.
    • RedHill Biopharma Ltd
    • Viatris Inc.
    • Yuhan Corporation
    • Zydus Lifesciences Limited
Product Code: SR112024A6684

The global peptic ulcer drugs market size reached US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.1 Billion by 2032, exhibiting a growth rate (CAGR) of 2.65% during 2024-2032. The increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various medications over invasive surgeries represent some of the key factors driving the market.

Peptic ulcers, or duodenal ulcers, are open sore that gradually develops and triggers defects in the lining of the stomach, small intestine, and lower esophagus. They are usually caused due to inflammation, radiation therapy, frequent oral and injectable administration of aspirins, and anti-inflammatory drugs. If peptic ulcers are left untreated, they might initiate severe pain in the mid- or upper-body parts, weight loss, internal bleeding, and severe blood loss, which require hospitalization. Currently, they can be treated with various drug types, including proton pump inhibitors (PPI), H2 antagonists, antibiotics, potassium-competitive acid blockers (P-CAB), antacids, and ulcer protectives. These medications reduce body aches, provide more time to heal, minimize acid secretion, offer resistance against bacterial infections, and protect the stomach from digestive juices. As a result, peptic ulcer drugs are extensively utilized by healthcare practitioners for the treatment of gastritis, gastroesophageal reflux disease (GERD), and duodenal ulcers.

Peptic Ulcer Drugs Market Trends:

The increasing prevalence of peptic ulcers, especially amongst the geriatric population, represents one of the key factors driving the market growth. Moreover, unhealthy lifestyle habits and rising instances of stomach cancer, is resulting in the growing number of individuals suffering from peptic ulcers. This, along with the shifting consumer inclination towards various peptic ulcer-curing drugs over invasive surgeries, which, in turn, is contributing to the market growth. In line with this, as compared to surgical procedures, several steroidal anti-inflammatory medications are minimally invasive, more affordable, and enable faster recovery while ensuring reduced blood loss. Additionally, the ongoing approvals of peptic ulcer drugs and several government investments in pharmaceutical companies for the formulation of medications are supporting the market growth. This is further influenced by the continuous conduction of clinical trials for new drug formation to overcome complications and the ineffectiveness of present drugs in the market. Moreover, the increasing consumer awareness regarding the benefits of cost-effective peptic ulcer drugs and their easy availability across multiple distribution channels is favoring the market growth. The advent of artificial intelligence (AI)-based pathology testing technology to perform diagnostic and forensic operations is also propelling the market growth. Other factors, such as extensive research and development (R&D) activities to enhance product efficacy and the increasing investments in the development of the over the counter (OTC) medications for treating peptic ulcers, are positively impacting the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global peptic ulcer drugs market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product type, ulcer type, and distribution channel.

Product Type Insights:

Proton Pump Inhibitors

Potassium-Competitive Acid Blocker (P-CAB)

Antacids

H2-Antagonists

Antibiotics

Ulcer protective

The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the product type. This includes proton pump inhibitors, potassium-competitive acid blocker (P-CAB), antacids, H2-antagonists, antibiotics, and ulcer protective. According to the report, antibiotics represented the largest segment.

Ulcer Type Insights:

Gastric Ulcer

Duodenal Ulcer

Others

A detailed breakup and analysis of the peptic ulcer drugs market based on the ulcer type has also been provided in the report. This includes gastric ulcer, duodenal ulcer, and others. According to the report, duodenal ulcer accounted for the largest market share.

Distribution Channel Insights:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The report has also provided a detailed breakup and analysis of the peptic ulcer drugs market based on the distribution channel. This includes hospital, retail and online pharmacies. According to the report, hospital pharmacies represented the largest segment.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for peptic ulcer drugs. Some of the factors driving the North America peptic ulcer drugs market included the increasing prevalence of peptic ulcers, especially amongst the geriatric population and shifting consumer inclination toward various peptic ulcer curing drugs over invasive surgeries and the fueling need for over-the-counter (OTC) medications in the healthcare sector.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global peptic ulcer drugs market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, Novitium Pharma LLC, Pfizer Inc., PharmaKing Co. Ltd., RedHill Biopharma Ltd, Viatris Inc., Yuhan Corporation, Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global peptic ulcer drugs market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global peptic ulcer drugs market?
  • What are the key regional markets?
  • Which countries represent the most attractive peptic ulcer drug markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the ulcer type?
  • What is the breakup of the market based on the distribution channel?
  • What is the competitive structure of the global peptic ulcer drugs market?
  • Who are the key players/companies in the global peptic ulcer drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Peptic Ulcer Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Proton Pump Inhibitors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Potassium-Competitive Acid Blocker (P-CAB)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Antacids
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 H2-Antagonists
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Antibiotics
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Ulcer Protective
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Ulcer Type

  • 7.1 Gastric Ulcer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Duodenal Ulcer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 AstraZeneca plc
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Boehringer Ingelheim International GmbH
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Novitium Pharma LLC
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Pfizer Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PharmaKing Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 RedHill Biopharma Ltd
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Viatris Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Yuhan Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zydus Lifesciences Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Peptic Ulcer Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Peptic Ulcer Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Peptic Ulcer Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Peptic Ulcer Drugs Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Peptic Ulcer Drugs Market: Breakup by Ulcer Type (in %), 2023
  • Figure 6: Global: Peptic Ulcer Drugs Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Peptic Ulcer Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Peptic Ulcer Drugs (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Peptic Ulcer Drugs (Potassium-Competitive Acid Blocker (P-CAB)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Peptic Ulcer Drugs (Antacids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Peptic Ulcer Drugs (Antacids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Peptic Ulcer Drugs (H2-Antagonists) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Peptic Ulcer Drugs (H2-Antagonists) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Peptic Ulcer Drugs (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Peptic Ulcer Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Peptic Ulcer Drugs (Ulcer Protective) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Peptic Ulcer Drugs (Ulcer Protective) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Peptic Ulcer Drugs (Gastric Ulcer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Peptic Ulcer Drugs (Duodenal Ulcer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Peptic Ulcer Drugs (Other Ulcer Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Peptic Ulcer Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Peptic Ulcer Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Peptic Ulcer Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Peptic Ulcer Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: North America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: North America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: United States: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: United States: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Canada: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Canada: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Asia-Pacific: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Asia-Pacific: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: China: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: China: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Japan: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Japan: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: India: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: India: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: South Korea: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: South Korea: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Australia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Australia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Indonesia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Indonesia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Europe: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Europe: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Germany: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Germany: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: France: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: France: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: United Kingdom: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: United Kingdom: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Italy: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Italy: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Spain: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Spain: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Russia: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Russia: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Latin America: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Latin America: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Brazil: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Brazil: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Mexico: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Mexico: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Middle East and Africa: Peptic Ulcer Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Middle East and Africa: Peptic Ulcer Drugs Market: Breakup by Country (in %), 2023
  • Figure 80: Middle East and Africa: Peptic Ulcer Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Global: Peptic Ulcer Drugs Industry: Drivers, Restraints, and Opportunities
  • Figure 82: Global: Peptic Ulcer Drugs Industry: Value Chain Analysis
  • Figure 83: Global: Peptic Ulcer Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Peptic Ulcer Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Ulcer Type (in Million US$), 2024-2032
  • Table 4: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Peptic Ulcer Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Peptic Ulcer Drugs Market: Competitive Structure
  • Table 7: Global: Peptic Ulcer Drugs Market: Key Players